default author photo

Feipeng Zhang

Shandong First Medical University

Qingdao

China

  • Shandong First Medical University

SCHOLARLY PAPERS

1

DOWNLOADS

16

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Identification of a Novel, Potent, and Orally Bioavailable Oxadiazole-Based Sphingosine Kinases Inhibitor from Virtual Screening and Rational Structural Optimization for the Treatment of Prostatic Cancer

Number of pages: 58 Posted: 18 Dec 2024
Tong Li, Xiujuan Shi, Zhiqiang Qu, Haiyang Wang, Fuxun Huang, Junru Liu, Xiaoqing Xu, Cunzhe Lin, Hongcai Li, Xi Qiu, Zhaoyang Li, Yuanyuan Liu, Yuqi Gao, Xiaodong Zhao, Yanling Mu, Qingqiang Yao, Zhengguo Cui, Feipeng Zhang, Tiandi Ding, Xuerui Zhang and Liu Bo
Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, affiliation not provided to SSRN, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, University of Fukui, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University and Shandong First Medical University
Downloads 16 (1,491,251)
Citation 1

Abstract:

Loading...

Sphingosine kinase inhibitors, Computer-aided drug design, S1P, structure-activity relationship